MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · IEX Real-Time Price · USD
44.77
-0.14 (-0.31%)
At close: Jul 26, 2024, 4:00 PM
47.00
+2.23 (4.98%)
After-hours: Jul 26, 2024, 4:26 PM EDT
MLTX Market Cap
MLTX has a market cap or net worth of $2.81 billion as of July 26, 2024. Its market cap has increased by 7.90% in one year.
Market Cap
2.81B
Enterprise Value
2.27B
1-Year Change
7.90%
Ranking
Category
Stock Price
$44.77
Market Cap Chart
Since October 20, 2020, MLTX's market cap has increased from $135.30M to $2.81B, an increase of 1,980.48%. That is a compound annual growth rate of 123.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 2.87B | -23.94% |
| Dec 29, 2023 | 3.77B | 581.44% |
| Dec 30, 2022 | 553.40M | 278.01% |
| Dec 31, 2021 | 146.40M | -13.01% |
| Dec 31, 2020 | 168.30M | 24.39% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ACADIA Pharmaceuticals | 3.05B |
| iRhythm Technologies | 3.03B |
| TG Therapeutics | 3.03B |
| Rhythm Pharmaceuticals | 3.01B |
| LivaNova | 2.91B |
| Morphic Holding | 2.83B |
| Envista Holdings | 2.80B |
| Apogee Therapeutics | 2.79B |